Larvol Delta - Biomind-Labs-to-Advance-a-Phase-II-Clinical-Trial-on-DMT-for-TreatmentResistant-Depression

N, N-dimethyltryptamine (BMND02) - Biomind

https://www.businesswire.com/news/home/20210818005361/en/Biomind-Labs-to-Advance-a-Phase-II-Clinical-Trial-on-DMT-for-Treatment-Resistant-Depression

Aug 18, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev